We constructed a new prognostic indicator (KC) based on the Ki-67 index and CEA levels, and patients were divided into two groups: the KC(-) group (low Ki-67 index and normal CEA) and KC(+) group (elevated Ki-67 index and/or elevated CEA). The gene discussed is MKI67; the disease is keratoconus.